Study of Potential applications of Ferrocene functionalized derivatives for its anticancer, antimalarial, antifungal, antiviral and antitubercular properties.


EOI: 10.11242/viva-tech.01.05.246

Download Full Text here



Citation

Ajitkumar V. Ingle, Shrimant V. Rathod, Sheetal Powar, Kailas W. Shinde , "Study of Potential applications of Ferrocene functionalized derivatives for its anticancer, antimalarial, antifungal, antiviral and antitubercular properties. ", VIVA-IJRI Volume 1, Issue 5, Article 246, pp. 1-5, 2022. Published by Computer Engineering Department, VIVA Institute of Technology, Virar, India.

Abstract

Ferrocene and its derivatives have a wide range of medicinal applications such as anticancer, antitubercular, antifungal, antiviral, antibacterial, analgesics, etc. This study specifically focusses on the discussion of reported potential biological activity applications of Ferrocene functionalized derivatives for its anticancer, antiviral, antifungal, antimalarial and antitubercular properties.

Keywords

Applications, Biological activities, Ferrocene derivatives.

References

  1. “Kealy T J and Pauson P L, Nature, 1951, 168, 1039.
  2. Miller S A, Tebboth J A and Tremaine J F, J Chem Soc., 1952, 632.
  3. Kopf-Maier P and Kopf H, Chem Rev., 1987, 87, 307.
  4. 4. Biot C, Delhaes L, N’Diaye C M, Maciejewski L A, Camus D and Dive D, Bioorg Med Chem., 1999, 7, 2843.
  5. Epton R, Marr G and Rogers G K, J Organomet Chem., 1976, 10, C42.
  6. Kaifer A E and de Mendoza J, Comprehensive Supramolecular Chemistry, (Elsevier, Oxford) 1996, 1, 701.
  7. Roth B, Strelitz J Z and Rauckman B S, J Med Chem., 1980, 23, 379.
  8. Yao T and Rechnitz G A, Biosensors, 1987, 3, 307.
  9. Zhu H, Lin H, Guo H and Yu L, Mat Sci Eng B., 2007, 101, 138.
  10. Fang J, Jin Z, Li Z and Liu W, J Organomet Chem., 2003, 1, 674.
  11. Kargaokar S S, Patil P H, Shah M T and Parekh H H, Indian J Pharm Sci., 1996, 58, 222.
  12. Palaskar E, Aytemir M, Uzbay I T and Erol D, Eur J Med Chem., 2001, 36, 539-543.
  13. Bilgin A A, Palaskar E and Sunal R, Aezneim Forsch Drug Res., 1993, 43, 1041.
  14. Ozdemir Z, Kandilici H B, Gumusel B, Calis U and Bilgin A A, Eur J Med Chem., 2007, 42, 373-379.
  15. Ruhoglus O, Ozdemir Z, Calis U, Gumusel B and Bilgin A A, Aezneim Forsch, Drug Res., 2005, 55, 431-436.
  16. Udupi R H, Kushnoor A R and Bhat A R, Indian J Hetrocyclic Chem., 1998, 8, 63.
  17. Taylor E C and Patel H H, Tetrahedron, 1992, 48, 8089-8100.
  18. Regaila H A, El-Bayanki A K and Hammad M, Egypt J Chem., 1979, 20, 197.
  19. Krishna R B, Panade R, Bhaithwal S P and Parmar S S, Eur Med J Chem., 1980, 15567.
  20. Husain M J and Shukla S, Indian J Chem., 1986, 25B, 983.
  21. Turan-Zitouni G, Chevallet P, Kilic F S and Erol K, Eur J Med Chem., 2000 , 35, 635–641.
  22. Jeong T S, Kim K S, Kim J R, Cho K Y and Lee S, Bioorg Med Chem Lett., 2004, 14, 2719–2723.
  23. Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P, Ferlinib C and Scambia G, Bioorg Med Chem Lett., 2005, 15, 4632–4635.
  24. Roecker A J, Coleman P J, Mercer S P, Schreier J D, Buser C A, Walsh E S, Hamilton K, Lobell R B, Tao W, Diehl R E, South V J, Davide J P, Kohl N E, Yan Y, Kuo L C, Li C, Fernandez C-Metzler, Mahan E A, Prueksaritanont T and Hartman G D, Bioorg Med Chem Lett., 2007, 17, 5677–5682.
  25. Fu N, Yuan Y, Pang M, Wang J and Peppe C, J Organomet Chem., 2003, 672, 52.
  26. Braga D, Addario D and Polito M, Organometallics, 2004, 23, 2810.
  27. Zhou W, Ji S and Shen Z, J Organomet Chem., 2006, 691, 1356.
  28. Joksović M, Ratković Z, Vukićević M and Vukićević R D, Synlett, 2006, 16, 2581.
  29. Mochida T, Shimizu F, Shimazu H, Okawaza K, Sato F and Kuwahara D, J Organomet Chem., 2007, 692, 1834.
  30. V. J. Fiorina, R. J. Dubois and S. Brynes, J. Med. Chem., 1978, 21, 393–395.
  31. P. Ko¨pf-Maier, H. Ko¨pf and E. W. Neuse, J. Cancer Res. Clin. Oncol., 1984, 108, 336–340.
  32. L. V. Popova, V. N. Babin, Y. A. Belousov, Y. S. Nekrasov A. E. Snegireva, N. P. Borodina, G. M. Shaposhnikova O. B. Bychenko, P. M. Raevskii, N. B. Morozova, A.I Iiyina and K. G. Shitkov, Appl. Organomet. Chem., 1993, 7, 85–94.
  33. A. J. Corry, A. Goel, S. R. Alley, P. N. Kelly, D. O’Sullivan, D. Savage and P. T. M. Kenny, J. Organomet. Chem., 2007, 692, 1405–1410.
  34. 58 A. Goel, D. Savage, S. R. Alley, P. N. Kelly, D. O’Sullivan, H. Mueller-Bunz and P. T. M. Kenny, J. Organomet. Chem., 2007, 692, 1292–1299.
  35. A. Mooney, A. J. Corry, D. O’Sullivan, D. K. Rai and P. T. M. Kenny, J. Organomet. Chem., 2009, 694, 886–894.
  36. A. Mooney, A. J. Corry, C. N. Ruairc, T. Mahgoub, D. O’Sullivan, N. O’Donovan, J. Crown, S. Varughese S. M. Draper, D. K. Rai and P. T. M. Kenny, Dalton Trans., 2010, 39, 8228–8239
  37. Y. N. Vashisht Gopal, D. Jayaraju and A. K. Kondapi, Arch. Biochem. Biophys., 2000, 376, 229–235
  38. A. D. Sai Krishna, G. Panda and A. K. Kondapi, Arch. Biochem. Biophys., 2005, 438, 206–216
  39. A. Nguyen, A. Vessie`res, E. A. Hillard, S. Top, P. Pigeon and G. Jaouen, Chimia, 2007, 61, 716–724.
  40. 39 E. A. Hillard, A. Vessie`res and G. Jaouen, Top. Organomet. Chem., 2010, 32, 81–117
  41. V. Craig Jordan, Curr. Probl. Cancer, 1992, 16, 134–176
  42. Wani, W.A.; Jameel, E.; Baig, U.; Mumtazuddin, S.; Hun, L.T. Ferroquine and its derivatives: New generation of antimalarial agents. Eur. J. Med. Chem. 2015, 101, 534–551.
  43. Reiter, C.; Fröhlich, T.; Zeino, M.; Zeino, M.; Marschall, M.; Bahsi, H.; Leidenberger, M.; Friedrich, O.; Kappes, B.; Hampel, F.; et al. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur. J. Med. Chem. 2015, 97, 164–172
  44. Reiter, C.; Çapcı Karagöz, A.; Fröhlich, T.; Klein, V.; Zeino, M.; Viertel, K.; Held, J.; Mordmüller, B.; Emirdağ Öztürk, S.; Anıl, H.; et al. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur. J. Med. Chem. 2014, 75, 403–412.
  45. C. Biot, N. François, L. Maciejewski, J. Brocard, D. Poulain, Bioorg. Med. Chem. Lett. 10 (2000) 839–841.
  46. Z.H. Chohan, Appl. Organomet. Chem. 20 (2006) 112–116
  47. H. Gopi, S. Cocklin, V. Pirrone, K. McFadden, F. Tuzer, I. Zentner, S. Ajith, S. Baxter, N. Jawanda, F.C. Krebs, I.M. Chaiken, J. Mol. Recognit. 22 (2009) 169– 174
  48. V.R. Gadhachanda, K.J. Eastman, Q. Wang, A.S. Phadke, D. Patel, W. Yang, C.W. Marlor, M. Deshpande, M. Huang, J.A. Wiles, Bioorg. Med. Chem. Lett. 28 (2018) 3463–3471.
  49. I. Ruiz, S. Chevaliez, J.-M. Pawlotsky, Curr. Hepatol. Rep. 16 (2017) 184–191
  50. Mahajan, A., Kremer, L., Louw, S., Guéradel, Y., Chibale, K. and Biot, C., 2011. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones. Bioorganic & Medicinal Chemistry Letters, 21(10), pp.2866-2868.
  51. Aman Mahajan a , Laurent Kremer b,c , Stefan Louw a , Yann Guéradel d,e , Kelly Chibale a , Christophe Biot d,e, Bioorganic & Medicinal Chemistry Letters Volume 21, Issue 10, 15 May 2011, Pages 2866-2868
  52. P. Dandawate et al Carbohydrate Polymers 108 (2014) 135–144